Key Insights

Highlights

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05989620RecruitingPrimary

Long-Term Development of Muscular Dystrophy Outcome Assessments

Showing all 1 trials

Research Network

Active Sponsors

  • Muscular Dystrophy Association1
  • Virginia Commonwealth University1

Top Investigators

Related Conditions

  • Lgmd2x1
  • Lgmd2y1
  • Lgmd2b1
  • Lgmd1g1
  • Lgmd1h1

Activity Timeline